Literature DB >> 24577843

Antiphopholipid antibodies and functional activated protein C resistance in patients with breast cancer during anthracycline-based chemotherapy administered through an intravenous port-catheter device.

A A Soliman1, R Csorba, A Ullrich, P Tsikouras, W Rath, G-F von Tempelhoff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24577843     DOI： 10.1177/1076029613508598

Source DB:  PubMed          Journal:  Clin Appl Thromb Hemost        ISSN： 1076-0296            Impact factor:   2.389


× No keyword cloud information.
  2 in total

1.  Functional impairment of activated protein C in breast cancer - relationship to survival outcomes.

Authors:  Mario Roselli; Patrizia Ferroni; Silvia Riondino; Sabrina Mariotti; Ilaria Portarena; Jhessica Alessandroni; Cristiano Ialongo; Renato Massoud; Leopoldo Costarelli; Francesco Cavaliere; Sergio Bernardini; Fiorella Guadagni
Journal:  Am J Cancer Res       Date:  2016-06-01       Impact factor: 6.166

2.  Systematic review of observational studies reporting antiphospholipid antibodies in patients with solid tumors.

Authors:  Noha Abdel-Wahab; Jean H Tayar; Faisal Fa'ak; Gaurav Sharma; Maria A Lopez-Olivo; Abdelrahman Yousif; Tasneam Shagroni; Sami Al-Hawamdeh; Cristhiam M Rojas-Hernandez; Maria E Suarez-Almazor
Journal:  Blood Adv       Date:  2020-04-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.